Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells

Xiaolong Wei, Mazhar Adli, Harun Öztürk et al.|Proceedings of the National Academy of Sciences|2020

Cited by 113